The read at a glance
Computed from the FY2025 annual filing. Full history and the components behind each score are in the app.
- Distress risk · Altman Z-Score -0.38 — distress zone — historically elevated failure riskWatch
- Earnings-manipulation signal · Beneish M -2.58 — no flag raisedOK
- Earnings quality 88/100 — accruals in line with cashOK
Where the revenue comes from
Fiscal 2025, as Lifevantage Corp reports it. History and quarterly detail are in the app.
- Protandim® product line$95.3M
- LifeVantage® product line$56.2M
- TrueScience® product line$48.7M
- AXIO® product line$15.3M
- Other$5.7M
Leadership changes
From Lifevantage Corp's own filings, the day they're filed.
- Ray Greer · CEO · appointmenteff. 2026-04-15
- Michael Beindorff · CEO · departureeff. 2026-04-13
- Steven R. Fife · Chief Executive Officer · departureeff. 2026-02-04
Latest filings
- 8-K · Company announcement2026-05-06
- 10-Q · Quarterly report2026-05-06
- 8-K · Company announcement2026-04-16
- 10-Q · Quarterly report2026-02-04
- 8-K · Company announcement2026-02-04
In the full recordFree for 14 days
- The filings, readable — with what changed vs the prior year highlighted🔒
- Full financial statements, industry-aware, every figure source-linked🔒
- Forensic score history & components — the trend, not one year🔒
- Ownership: insider buys/sells, clusters, activist stakes🔒
- Ana — ask anything about Lifevantage Corp, every answer cited🔒
- The Intelligence Brief — added when Lifevantage Corp's brief passes our SEC-figure check🔒
Every figure links to the filing it came from, and analysis whose figures don't match SEC data is rejected before publication.
14-day free trial, no credit card. For research purposes only; not investment advice.